Landau, Ruth <br/><br/>
Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Dec 2005 
 - 656-63 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/j.clpt.2005.08.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-2 Receptor Agonists<br/>Adrenergic beta-Agonists--administration & dosage<br/>Adult<br/>Alleles<br/>Amino Acid Substitution--genetics<br/>Arginine--genetics<br/>Female<br/>Gene Frequency<br/>Glycine--genetics<br/>Haplotypes<br/>Hexoprenaline--administration & dosage<br/>Homozygote<br/>Humans<br/>Infant, Low Birth Weight<br/>Infant, Newborn<br/>Obstetric Labor, Premature--genetics<br/>Pregnancy<br/>Pregnancy Outcome<br/>Receptors, Adrenergic, beta-2--genetics<br/>Respiratory Distress Syndrome, Newborn--genetics<br/>Tachycardia--genetics<br/>Tocolysis--methods<br/>Tocolytic Agents--administration & dosage